TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2019

Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.

Daisuke Takahari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.